In breast carcinomas, E2F1 expression is correlated with proliferation [29] and the poor survival of lymph node-positive breast cancer patients treated with fluorouracil, doxorubicin, and cyclophosphamide [37]. The gene discussed is E2F1; the disease is breast carcinoma.